Skip to main content
SLXN logo

SLXN

Silexion Therapeutics Corp
$2.85 +0.21 (+7.75%) At close · Jul 6
Market Cap
$9.49M
Shares
3,330,785

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 7
Total Value: $46,690
Total Shares: 36,479

Institutional Ownership Trend

4 quarters

Holder Concentration

Across 7 13F filers · Δ vs Dec 31, 2025
Top Holder
57.4%
Jun 2025 → Mar 2026 · range 54.9% – 66.6%
−9.3 pts
Top 5
99.9%
Jun 2025 → Mar 2026 · range 99.9% – 100.0%
+0.0 pts
Top 10
100.0%
Jun 2025 → Mar 2026 · range 100.0% – 100.0%
0.0 pts
HHI
4,383
Jun 2025 → Mar 2026 · range 4,144 – 5,048
Highly concentrated−449

Quarterly Activity

vs Dec 31, 2025
New
1
Increased
1
Decreased
2
Sold Out
0
Unchanged
3
Holder count: +1
Institutional value: +32.8%
Shares held: +99.2%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
No fully closed positions this quarter.
Showing 7 of 7
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 2022416 CUSIP G1281K130 13F (30d) 1 filings 1 filers Visit website